Page last updated: 2024-08-18

trehalose and Disease, Pulmonary

trehalose has been researched along with Disease, Pulmonary in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altavilla, D; Bellocco, E; Bitto, A; Fiumara, T; Laganà, G; Magazù, S; Migliardo, F; Minutoli, L; Polito, F; Squadrito, F; Venuti, FS1
Dennis, JJ; Finlay, WH; Lynch, KH; Matinkhoo, S; Vehring, R1
Klumpp, J; Lavigne, R; Singh, A; Van den Mooter, G; Vandenheuvel, D; Vandersteegen, K1
Gal, A; Jeon, YJ; Perez, RL; Roman, J1
Asselineau, J; Bekierkunst, A; Lederer, E; Toubiana, MJ; Toubiana, R; Yarkoni, E1

Other Studies

5 other study(ies) available for trehalose and Disease, Pulmonary

ArticleYear
Trehalose: a biophysics approach to modulate the inflammatory response during endotoxic shock.
    European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3

    Topics: Animals; Anti-Inflammatory Agents; Biophysical Phenomena; Biophysics; Blood Pressure; Cell Membrane; Cytokines; Diffusion; Disease Models, Animal; Edema; I-kappa B Proteins; Lipopolysaccharides; Liver; Liver Diseases; Lung; Lung Diseases; Male; Models, Biological; Neutrons; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Scattering, Radiation; Shock, Septic; Sucrose; Time Factors; Toll-Like Receptor 4; Trehalose; Water

2008
Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.
    Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:12

    Topics: Administration, Inhalation; Aerosols; Bacteriophages; Caseins; Desiccation; Drug Compounding; Dry Powder Inhalers; Excipients; Humans; Lung; Lung Diseases; Myoviridae; Particle Size; Polyethylene Glycols; Powders; Pseudomonas aeruginosa; Respiratory Tract Infections; Surface-Active Agents; Trehalose

2011
Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 84, Issue:3

    Topics: Administration, Inhalation; Bacterial Infections; Bacteriophages; Chemistry, Pharmaceutical; Desiccation; Dextrans; Drug Compounding; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Feasibility Studies; Humans; Lactose; Lung Diseases; Particle Size; Powders; Pseudomonas; Staphylococcus; Temperature; Trehalose

2013
Distribution of extracellular matrices, matrix receptors, and transforming growth factor-beta 1 in human and experimental lung granulomatous inflammation.
    The American journal of the medical sciences, 1995, Volume: 309, Issue:3

    Topics: Animals; Collagen; Extracellular Matrix; Fibronectins; Granuloma; Humans; Integrins; Lung Diseases; Mice; Receptors, Cell Surface; Sarcoidosis, Pulmonary; Transforming Growth Factor beta; Trehalose

1995
Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).
    Journal of the National Cancer Institute, 1973, Volume: 51, Issue:2

    Topics: Animals; Carcinoma, Ehrlich Tumor; Disaccharides; Glycolipids; Graft Rejection; Granuloma; Lung Diseases; Mice; Neoplasm Transplantation; Transplantation, Homologous; Trehalose

1973